KNSA
Kiniksa Pharmaceuticals International, plc 9/4/2025, 10:38:29 AM
NasdaqGS
USD
EQUITY
At Close
$35.48
+15.54 (+77.93%)
Volume
600,202
-11.1% vs Period Avg
Market Cap
2.63B
NasdaqGS
Period
No AI Analysis Available
Generate a comprehensive AI analysis for KNSA to get insights on valuation, growth prospects, and investment recommendations.
Valuation
-
Profitability
1.0%
0.5%
0.6%
53.1%
0.8%
0.9%
Growth
56.2%
80.5%
-
-
119.4%
Financial Health
-
Forward Looking
Strong Buy
$40.83
-
$131.13
Mid-Cap
Risk & Technical
0.20
$35.53 / $17.82
71.48
6.2%
Shareholder Returns
-
-
-
-5.6%
2.5%